ZOLL Showcases Expanded Portfolio of Products at Arab Health 2017
|
By HospiMedica International staff writers Posted on 30 Jan 2017 |

Image: ZOLL Medical displayed an expanded portfolio of resuscitation and critical care products and technologies at Arab Health 2017 (Photo courtesy of ZOLL Medical).
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, displayed its expanded and fully integrated portfolio of resuscitation and acute critical care technologies and data management solutions at Arab Health 2017 held in Dubai, United Arab Emirates.
ZOLL, an Asahi Kasei group company, develops and markets medical emergency care devices and software solutions, including products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation. The Asahi Kasei group’s health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents.
At the four-day event held from January 30 to February 2, 2017, at the Dubai International Convention & Exhibition Centre, ZOLL displayed new additions to its portfolio, including the ZOLL AED 3 automated external defibrillator and the ZOLL AED 3 BLS (basic life support). The ZOLL AED 3 BLS model is designed specifically for the needs of first responders with the CPR Dashboard and the ability to deliver the patient record directly to health care providers.
Additional resuscitation solutions from ZOLL on display at Arab Health 2017 included its small and lightweight X Series monitor/defibrillator, and the ResQCPR System, which is a combination of two medical devices, the CardioPump ACD-CPR device and the ResQPOD impedance threshold device (ITD). The devices are used together during CPR to create an enhanced vacuum in the chest that improves blood flow to the brain and vital organs.
Also on display at the event were ZOLL’s resuscitation solutions for the hospital environment, including its 731 family of portable ventilators, the AutoPulse Resuscitation System, an automated CPR device especially designed for use during transport of critically-ill patients, the R Series monitor/defibrillator, Intravascular Temperature Management (IVTM), which offers health care providers the precision and control they need to rapidly, safely, and effectively manage the core body temperature of critically-ill or surgical patients, and the Thermogard XP, a temperature management system that delivers accurate, easy-to-use, and cost-effective control for both cooling and warming applications.
ZOLL, an Asahi Kasei group company, develops and markets medical emergency care devices and software solutions, including products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation. The Asahi Kasei group’s health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents.
At the four-day event held from January 30 to February 2, 2017, at the Dubai International Convention & Exhibition Centre, ZOLL displayed new additions to its portfolio, including the ZOLL AED 3 automated external defibrillator and the ZOLL AED 3 BLS (basic life support). The ZOLL AED 3 BLS model is designed specifically for the needs of first responders with the CPR Dashboard and the ability to deliver the patient record directly to health care providers.
Additional resuscitation solutions from ZOLL on display at Arab Health 2017 included its small and lightweight X Series monitor/defibrillator, and the ResQCPR System, which is a combination of two medical devices, the CardioPump ACD-CPR device and the ResQPOD impedance threshold device (ITD). The devices are used together during CPR to create an enhanced vacuum in the chest that improves blood flow to the brain and vital organs.
Also on display at the event were ZOLL’s resuscitation solutions for the hospital environment, including its 731 family of portable ventilators, the AutoPulse Resuscitation System, an automated CPR device especially designed for use during transport of critically-ill patients, the R Series monitor/defibrillator, Intravascular Temperature Management (IVTM), which offers health care providers the precision and control they need to rapidly, safely, and effectively manage the core body temperature of critically-ill or surgical patients, and the Thermogard XP, a temperature management system that delivers accurate, easy-to-use, and cost-effective control for both cooling and warming applications.
Latest ARAB HEALTH 2017 News
- Dräger Introduces New Incubator and Baby Warmer
- Kastus Showcases Superbug-Killing Antimicrobial Solutions
- Esaote Presents New Ultrasound Platform at Arab Health 2017
- Merivaara Showcases Q-Flow Surgical Light at Arab Health
- Rober Showcases Pressure Ulcer Protection for Critically Ill Patients
- Finland Showcases Cutting-Edge Health Services and Technologies
- US Medical Leaders Build on Professional Partnerships at Arab Health 2017
- Rostec Presents Newborn Care Technologies
- Ascom Unveils Nurse Call Innovations
- Mediplus Launches IV Drug Delivery System at Arab Health Show
- UK Pavilion Performs Groundbreaking Surgery at Dubai Trade Show
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel








